While switching from sugar may help reduce calories, there’s more to consider when it comes to artificial sweeteners.

Studies have also shown that sweeteners can stimulate the same neurons as the appetite hormone, leptin. Over time, this could ...

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Researchers from the University of Kentucky have taken a closer look at the relationship between obesity and kidney disease ...

With American Diabetes Alert Day approaching on March 25, 2025, the Molly Diabetes Education and Management Center for Adults and Children urges individuals, especially those struggling with ...

Apr. 25, 2025 — It's no secret that our waistlines often expand in middle-age, but the problem isn't strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk ...

Apr. 8, 2025 — New research has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes -- not the presence of certain fats, but their suppression. The study ...

Comorbidities of interest were diabetes and tobacco smoking, both of which have been linked to skin infection in minor skin procedures, as well as obesity, which—along with diabetes and smoking ...

Individuals with obesity or diabetes tend to concentrate on blood sugar or weight control, yet the liver is one of the most ...

Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or ...